Zhongnan Medical Journal Press

Home Results

A total of 7 result was found. Results that relate to HU Jing

Visualization analysis on research progress and trends of Ziziphi Spinosae Semen from 2000 to 2022

Published on Frontiers in Pharmaceutical Sciences 2024,27(2):242-254.
4366 times 1274 times

QU Tong LI Ning REN Hui LU Wenjing CUI Xiaomin HU Jing CHEN Zhiyong ZHANG Hong

Chinese medicine Ziziphi Spinosae Semen Visualization analysis Research progress Chemical composition Pharmacology Clinical application
Details
Application of micro-macroscopical identification in quality acceptance of Chinese herbal pieces in medical institutions

Published on Frontiers in Pharmaceutical Sciences 2024,27(8):1309-1319.
2515 times 512 times

ZHANG Lulu LOU Zhaohuan ZHU Xuemei CHEN Yongcai ZHU Jingjing HUANG Leyan

Micro-macroscopical identification Chinese herbal pieces Quality acceptance Application value Pharmacy administration Medical institution Eriocauli flos Aurantii fructus Chaenomelis fructus Perillae fructus Astragali complanati semen Selaginellae herba Lysimachiae herba Cyrtomium fortunei Root of Valvate actinidi
Details
Influencing factors of the therapeutic effect of PD-1 inhibitor pembrolizumab on cervical cancer

Published on Frontiers in Pharmaceutical Sciences 2024,27(8):1375-1382.
2013 times 388 times

HU Jinghua SANG Xuemei QIAO Wei ZHANG Miao

Programmed death-1 Programmed death-ligand 1 Pabolizumab Cervical carcinoma Tumor mutation burden Tumor infiltrating lymphocytes Neoantigen intra-tumoral heterogeneity
Details
Research progress on the chemical composition, pharmacological action, and clinical application of Ziziphi spinosae semen

Published on Frontiers in Pharmaceutical Sciences 2024,28(1):98-108.
8633 times 1012 times

QU Tong GENG Feifei LI Ning LU Wenjing REN Hui CUI Xiaomin HU Jing LIANG Chao CHEN Zhiyong ZHANG Hong

Ziziphi spinosae semen Chemical constituents Pharmacological action Clinical research Saponins Flavonoids Alkaloids aliphatic acids
Details
Data mining of adverse event of novel tetracycline-class drugs based on the FAERS database

Published on Chinese Journal of Pharmacoepidemiology 2024,33(11):1229-1238.
2066 times 358 times

LI Boyang HU Jing

New tetracycline-class Omadacycline Eravacycline Adverse drug events Data mining FAERS database
Details
Clinical efficacy analysis of cross-line immunotherapy in driver gene-negative advanced non-small cell lung cancer patients

Published on New Medicine 2025,35(2):151-161.
983 times 309 times

WANG Yuankun LU Jiahao HU Jing XIE Conghua

Cross-line immunotherapy Non-small cell lung cancer Immune checkpoint inhibitors Prognosis Driver gene-negative
Details
A case report of ischemic bowel disease caused by Shengxuexiaoban capsules

Published on Chinese Journal of Pharmacoepidemiology 2025,34(2):236-240.
924 times 123 times

XU Cuilin LI Binbin HU Jing HU Naizhong WANG Yanyan

Shengxuexiaoban capsules Ischemic bowel disease Adverse reactions
Details